{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Data+Collection&page=32", "query": { "intervention": "Data Collection", "page": 32 }, "page_size": 10 }, "pagination": { "page": 32, "page_size": 10, "total_count": 4189, "total_pages": 419, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Data+Collection&page=33&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Data+Collection&page=31&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-18T04:22:36.890Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00033371", "title": "Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colorectal Cancer", "Familial Adenomatous Polyposis" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "eflornithine", "type": "DRUG" }, { "name": "Laboratory biomarker analysis", "type": "OTHER" }, { "name": "Questionnaire administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 205, "start_date": "2001-12-13", "completion_date": "2009-03-24", "has_results": true, "last_update_posted_date": "2020-09-29", "last_synced_at": "2026-10-18T04:22:36.890Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00033371" }, { "nct_id": "NCT05352451", "title": "Values and Options in Cancer Care 2 (VOICE 2) A Randomized Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Communication, Multidisciplinary" ], "interventions": [ { "name": "Interventional Survey", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 29, "start_date": "2022-05-09", "completion_date": "2024-12-31", "has_results": false, "last_update_posted_date": "2025-04-09", "last_synced_at": "2026-10-18T04:22:36.890Z", "location_count": 1, "location_summary": "New Brunswick, New Jersey", "locations": [ { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05352451" }, { "nct_id": "NCT03952637", "title": "A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Lysosomal Diseases", "Gangliosidosis", "GM1" ], "interventions": [ { "name": "AAV9-GLB1", "type": "BIOLOGICAL" }, { "name": "Abdominal ultrasound", "type": "PROCEDURE" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Sirolimus", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Audiology assessment with ABR", "type": "DIAGNOSTIC_TEST" }, { "name": "Bone density scan (DEXA)", "type": "DIAGNOSTIC_TEST" }, { "name": "Electrocardiogram (EKG)", "type": "DIAGNOSTIC_TEST" }, { "name": "Echocardiogram", "type": "DIAGNOSTIC_TEST" }, { "name": "Electroencephalogram (EEG) awake and extended overnight", "type": "OTHER" }, { "name": "Laboratory tests", "type": "DIAGNOSTIC_TEST" }, { "name": "Lumbar puncture", "type": "PROCEDURE" }, { "name": "Brain MRI/MRS/fMRI", "type": "PROCEDURE" }, { "name": "Neurocognitive testing", "type": "BEHAVIORAL" }, { "name": "Neurology exam", "type": "OTHER" }, { "name": "PICC or other Central line placement", "type": "BEHAVIORAL" }, { "name": "Skeletal survey", "type": "PROCEDURE" }, { "name": "Skin biopsy", "type": "PROCEDURE" }, { "name": "Speech and modified barium swallow study", "type": "PROCEDURE" }, { "name": "Ophthalmology exam", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE", "DRUG", "DIAGNOSTIC_TEST", "OTHER", "BEHAVIORAL" ], "sponsor": "National Human Genome Research Institute (NHGRI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "12 Years", "sex": "ALL", "summary": "6 Months to 12 Years" }, "enrollment_count": 54, "start_date": "2019-08-19", "completion_date": "2030-01-01", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-10-18T04:22:36.890Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03952637" }, { "nct_id": "NCT04453072", "title": "A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity", "Malignant Neoplasm" ], "interventions": [ { "name": "Interview", "type": "OTHER" }, { "name": "Media Intervention", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Scale Device", "type": "OTHER" }, { "name": "Telephone-Based Intervention", "type": "BEHAVIORAL" }, { "name": "Text Message", "type": "OTHER" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "Jonsson Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "13 Years to 30 Years" }, "enrollment_count": 20, "start_date": "2020-07-01", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-05-11", "last_synced_at": "2026-10-18T04:22:36.890Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04453072" }, { "nct_id": "NCT04970212", "title": "Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Carcinoma, Hepatocellular", "Metastatic Liver Cancer" ], "interventions": [ { "name": "BioTraceIO Lite", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Techsomed Medical Technologies LTD", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 65, "start_date": "2021-09-24", "completion_date": "2022-10-08", "has_results": false, "last_update_posted_date": "2023-04-18", "last_synced_at": "2026-10-18T04:22:36.890Z", "location_count": 6, "location_summary": "Phoenix, Arizona • Stanford, California • Boston, Massachusetts + 3 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Stanford", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04970212" }, { "nct_id": "NCT06237322", "title": "Study of RE.DOCTOR Vitals® Software Accuracy", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Respiratory Disorder", "Cardiovascular Diseases", "Diabetes", "Pre-Diabetes", "Primary Care" ], "interventions": [], "intervention_types": [], "sponsor": "RE.DOCTOR LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "13 Years to 80 Years" }, "enrollment_count": 1000, "start_date": "2024-03-01", "completion_date": "2025-03-01", "has_results": false, "last_update_posted_date": "2024-02-05", "last_synced_at": "2026-10-18T04:22:36.890Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT06237322" }, { "nct_id": "NCT06056739", "title": "Alio WEAR Study: Long-term Wear of the Alio Platform", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "End Stage Kidney Disease" ], "interventions": [ { "name": "Alio platform", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Alio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2023-10-09", "completion_date": "2024-04-01", "has_results": false, "last_update_posted_date": "2023-10-11", "last_synced_at": "2026-10-18T04:22:36.890Z", "location_count": 1, "location_summary": "Huntley, Illinois", "locations": [ { "city": "Huntley", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06056739" }, { "nct_id": "NCT01334801", "title": "Biomarkers in Aortic Stenosis - B.A.S.S.", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Aortic Stenosis", "Disorder of Prosthetic Cardiac Valve", "Aortic Valve Insufficiency", "Mitral Valve Insufficiency", "Hypertrophic Cardiomyopathy", "Tricuspid Valve Insufficiency" ], "interventions": [ { "name": "Blood Draw", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 378, "start_date": "2010-07", "completion_date": "2020-01-31", "has_results": false, "last_update_posted_date": "2022-05-05", "last_synced_at": "2026-10-18T04:22:36.890Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01334801" }, { "nct_id": "NCT00482365", "title": "National Registry and Blood Bank of Patients With Liver Cancer", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Liver Cancer" ], "interventions": [ { "name": "biologic sample preservation procedure", "type": "OTHER" }, { "name": "medical chart review", "type": "OTHER" }, { "name": "Patient interview", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Vanderbilt-Ingram Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 151, "start_date": "2002-04", "completion_date": "2009-08", "has_results": false, "last_update_posted_date": "2013-08-19", "last_synced_at": "2026-10-18T04:22:36.890Z", "location_count": 3, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00482365" }, { "nct_id": "NCT06718907", "title": "Mitigating Response to Stressors in Pregnant Women", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pregnancy" ], "interventions": [ { "name": "Simulated stimuli", "type": "BEHAVIORAL" }, { "name": "Stress Management", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Nova Southeastern University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "37 Years", "sex": "FEMALE", "summary": "21 Years to 37 Years · Female only" }, "enrollment_count": 50, "start_date": "2024-12-20", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-02-25", "last_synced_at": "2026-10-18T04:22:36.890Z", "location_count": 1, "location_summary": "Davie, Florida", "locations": [ { "city": "Davie", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06718907" } ] }